Pay in 4 interest-free payments of $7.33 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
How GLP-1 Medications Support Weight Loss During Perimenopause Last reviewed June 3rd 2026 Navigating the journey of perimenopause can feel overwhelming
Preclinical research shows that GIP signaling: Promotes neuronal survival and reduces apoptosis (cell death) in the hippocampus, a brain region involved in pain memory and emotional processing of pain Enhances synaptic plasticity and BDNF expression, both of which are reduced in fibromyalgia Reduces oxidative stress in neural tissue by upregulating antioxidant enzymes These GIP-specific neuroprotective effects aren't available from GLP-1-only medications, giving tirzepatide a theoretical advantage for conditions involving neural dysfunction
Manage New Patient Enrollments with Caution : New patients, particularly those seeking Ozempic for weight loss (a non-FDA-approved use), should be enrolled cautiously
Regular movement: Even 20-30 minutes of walking daily stimulates colonic contractions and promotes regular bowel movements
By reducing hunger and supporting satiety, semaglutide helps patients consume fewer calories and lose weight steadily over time
